This all-new edition of "The Business of Innovation," hosted by Maria Bartiromo, will give you unprecedented access to what's happening in cities across the world: from reshaping them, to redefining healthcare, to rethinking work.
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. Dr. Steven Nissen, chairman of the Department of Cardiovascular Medicine at The Cleveland Clinic, shares his reaction with CNBC's Mike Huckman.